Brief: Aeterna Zentaris Secures European Patent Related To Use Of Macimorelin
19/04/2022 13:25
April 19 (Reuters) - Aeterna Zentaris Inc AEZS.TO :
* AETERNA ZENTARIS SECURES NEW EUROPEAN PATENT RELATED TO
USE OF
MACIMORELIN FOR THE DIAGNOSIS OF GROWTH HORMONE DEFICIENCY IN
ADULTS
Source text for Eikon: ID:nGNX2rghHS
Further company coverage: AEZS.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on COSCIENS Biopharma
See all newsBrief: COSCIENS Acquires Nualtis Corp
Refile: Canada's COSCIENS Biopharma Q2 net loss narrows on higher sales
Canada's COSCIENS Biopharma Q1 net income turns positive on discontinued German operations
Brief: Cosciens Biopharma Inc Not Aware Of Material Undisclosed Information Amid Recent Trading Activity
Brief: Cosciens Provides Strategic Update